Back to Search
VICTORIA MCLAUGHLIN, PHD, LPC, LSATP, ACS
PHD, LPC, LSATP, ACS
Professional Counselor
NPI: 1124570577IndividualAccepts Medicare
Specialties, Licenses & Credentials
Addiction (Substance Use Disorder) Counselor
Counselor — Addiction (Substance Use Disorder)
Code: 101YA0400X
0718000432(VA)0710102973(VA)
Professional CounselorPrimary
Counselor — Professional
Code: 101YP2500X
0701006808(VA)
Education
OTHER
Class of 2017
Research & Publications (20)
Updated evidence-based treatment algorithm in pulmonary arterial hypertension.
PMID 19555861·J Am Coll Cardiol·2009
6-review
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.
PMID 19389575·J Am Coll Cardiol·2009
6-review
Windblown lead carbonate as the main source of lead in blood of children from a seaside community: an example of local birds as "canaries in the mine".
PMID 19165402·Environ Health Perspect·2009
7-preclinical
Opportunities and challenges in the study of pulmonary arterial hypertension.
PMID 19119151·Am J Respir Crit Care Med·2009
8-other
The 4th World Symposium on Pulmonary Hypertension. Introduction.
PMID 19555852·J Am Coll Cardiol·2009
8-other
End points and clinical trial design in pulmonary arterial hypertension.
PMID 19555863·J Am Coll Cardiol·2009
6-review
Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis.
PMID 19487219·Rheumatology (Oxford)·2009
6-review
Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities.
PMID 18812445·Chest·2009
3-trial
A new approach to mitral valve repair for rheumatic disease: preliminary study.
PMID 19137791·J Heart Valve Dis·2008
8-other
Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion.
PMID 18094217·J Clin Pharmacol·2008
3-trial
Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.
PMID 18506008·Circulation·2008
4-observational
Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension.
PMID 17613405·J Heart Lung Transplant·2007
3-trial
Sickle cell disease-associated pulmonary hypertension: a coat of many colors.
PMID 17545455·Am J Respir Crit Care Med·2007
8-other
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.
PMID 17472992·Ann Rheum Dis·2007
4-observational
Transition from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial.
PMID 17400684·Chest·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 501 PRINCE GEORGE ST STE 209
WILLIAMSBURG, VA 23185 - Phone
- (757) 274-9354
Quick Facts
- NPI
- 1124570577
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile